Aclarion, Inc. is a healthcare technology firm specializing in software development for magnetic resonance spectroscopy (MRS) within the U.S. market. Its flagship product is the NOCISCAN-LS Post-Processor suite. This comprehensive suite includes NOCICALC-LS, which processes magnetic resonance spectroscopy (MRS) data from spinal discs to quantify degenerative pain biomarkers, and NOCIGRAM-LS, a vital clinical decision support tool. Initially named Nocimed, Inc., the company adopted the Aclarion, Inc. moniker in December 2021. Established in 2008, Aclarion, Inc. maintains its headquarters in San Mateo, California.
The current price of ACONW is $0.04 USD — it has increased by +38.49% in the past 24 hours. Watch Aclarion stock price performance more closely on the chart.
What is Aclarion stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Aclarion stocks are traded under the ticker ACONW.
What is Aclarion market cap?▼
Today Aclarion has the market capitalization of 27,041.3
When is the next Aclarion earnings date?▼
Aclarion is going to release the next earnings report on August 28, 2026.
What were Aclarion earnings last quarter?▼
ACONW earnings for the last quarter are -1.34 USD per share, whereas the estimation was -1.34 USD resulting in a +0% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Aclarion revenue for the last year?▼
Aclarion revenue for the last year amounts to 92,000 USD.
What is Aclarion net income for the last year?▼
ACONW net income for the last year is -13.99M USD.
How many employees does Aclarion have?▼
As of June 19, 2026, the company has 5 employees.
In which sector is Aclarion located?▼
Aclarion operates in the Health & Wellness sector.
When did Aclarion complete a stock split?▼
The last stock split for Aclarion was on January 30, 2025 with a ratio of 1:335.
Where is Aclarion headquartered?▼
Aclarion is headquartered in Broomfield, United States.